Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 94.20
+0.40 (0.43%)
Jul 22, 2026, 5:24 PM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 3.8 million as of July 24, 2026. Its market cap has decreased by -29.39% in one year.
Market Cap
3.80M
Enterprise Value
-5.39M
Revenue
720.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
94.20
ChartMarket Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 3.80M, a decrease of -90.57%. That is a compound annual growth rate of -34.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 3.80M | -22.72% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 107.33B |
| Danel (Adir Yeoshua) | 2.69B |
| Amal Holdings A.D. | 2.48B |
| BrainsWay | 2.00B |
| Evogene | 17.68M |
| Nextage Therapeutics | 13.14M |
| Bio-View | 12.01M |
| PsyRX CNS Bio-Tech | 8.90M |